Purpose Previous studies have shown an association of sarcopenia with adverse short-and
long-term outcomes in multiple gastrointestinal cancer types. We aimed to investigate the …

This study will address the prevalence of pre-therapeutic sarcopenia (PS) and its clinical
impact during cancer treatment among adult cancer patients≥ 18 years of age. A meta …

Growing evidence suggests that changes in muscle mass and function may further
contribute to health risk assessment in individuals who are obese. As numbers for both …

Background: Surgeons have historically used age as a preoperative predictor of
postoperative outcomes. Sarcopenia, the loss of skeletal muscle mass due to disease or …

Objectives After elective surgeries, low muscle mass and other specific body composition
indexes, assessed by computed tomography (CT), are associated with adverse outcomes …

Background Sarcopenic obesity (SO) has been indicated as a scientific and clinical priority
in oncology. This meta-analysis aimed to investigate the impacts of preoperative SO on …

Body composition performed by computed tomography (CT) impacts on cancer patients'
prognoses and responses to treatment. Myosteatosis has been related to overall survival …

Introduction The incidence of colorectal cancer (CRC) increases with age. In combination
with an ageing population, the number of older patients undergoing surgical treatment for …

Background & aims Sarcopenic obesity (SO) is associated with worse outcomes in patients
with colorectal cancer (CRC); however, the diagnostic methods and prevalence of SO vary …

Background Derangement of body composition has been associated with dismal long-term
survival in several gastrointestinal cancers including rectal tumors treated with neoadjuvant …